Additions to Methotrexate with Conventional and Biologic DMARDs in Rheumatoid Arthritis: Are there Difference in Subsequent Time to Treatment Failure?

被引：0
|
作者：
Moura, Cristiano [1 ]
Bykerk, Vivian [2 ]
Schieir, Orit
Valois, Marie-France [3 ]
Bartlett, Susan [3 ]
Hitchon, Carol [4 ]
Pope, Janet [5 ]
Boire, Gilles [6 ]
Haraoui, Boulos [7 ]
Keystone, Edward [8 ]
Tin, Diane [9 ]
Thorne, Carter [9 ]
Bernatsky, Sasha [10 ]
机构：
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[2] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[3] McGill Univ, Montreal, PQ, Canada
[4] Univ Manitoba, Winnipeg, MB, Canada
[5] Western Univ, Dept Med, Div Rheumatol, London, ON, Canada
[6] Univ Sherbrooke, Sherbrooke, PQ, Canada
[7] Inst Rhumatol Montreal, Montreal, PQ, Canada
[8] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada
[9] Southlake Reg Hlth Ctr, Newmarket, Suffolk, England
[10] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2018年 / 45卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
92
引用
收藏
页码：1004 / 1004
页数：1
相关论文
共 50 条
  • [41] RISK OF VENOUS THROMBOEMBOLISM IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC AND NON-BIOLOGIC DMARDS
    Maro, J. C.
    Menzin, T.
    Hornbuckle, K.
    Giles, J. T.
    Kavanaugh, A.
    Doerner, T.
    Martin, D.
    Huang, T.
    Salinas, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 932 - 932
  • [42] Methotrexate in treatment of rheumatoid arthritis
    Wiewiórowski, M
    Graczyk, J
    PTERIDINES, 1999, 10 (03) : 141 - 147
  • [43] Triple therapy with non-biologic DMARDs for rheumatoid arthritis or biologic therapy. Is it the same?
    Abud-Mendoza, Carlos
    Martinez-Martinez, Marco U.
    REUMATOLOGIA CLINICA, 2014, 10 (05): : 345 - 346
  • [44] SURVIVAL OF THE FIRST COURSE OF BIOLOGIC OR JAK INHIBITOR IN RHEUMATOID ARTHRITIS: ASSOCIATION WITH THE CHOICE OF AGENT AND CONCOMITANT CONVENTIONAL SYNTHETIC DMARDS
    Bredemeier, M.
    Duarte, A.
    Pinheiro, M.
    Stadler, B.
    Macieira, J. C.
    Ranza, R.
    Miranda, J.
    Valim, V.
    Castro, G.
    Bertolo, M.
    Sauma, M. D. F.
    Fernandes, V.
    Medeiros, A.
    Botelho, R.
    Brenol, C.
    Negrao Goncalo Dias, D.
    Carvalho, H.
    Studart, S.
    Da Rocha Castelar Pinheiro, G.
    Rocha, L.
    Pereira, I.
    Ohira Gazzeta, M.
    Maria Kakehasi, A.
    Louzada, P., Jr.
    Hayata, A. L. S.
    Pina, F.
    Lupo, C.
    Balarini, L.
    Silveira, I.
    Kowalski, S.
    Titton, D.
    Chakr, R.
    Ranzolin, A.
    Laurindo, I.
    Xavier, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 582 - 583
  • [45] DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis
    Wang, Susan Siyu
    Lewis, Myles J.
    Pitzalis, Costantino
    BIOMEDICINES, 2023, 11 (07)
  • [46] Treatment of rheumatoid arthritis with methotrexate alone and in combination with other conventional DMARDs using the T2T strategy. A cohort study
    Pedro Iván Santos-Moreno
    José de la Hoz-Valle
    Laura Villarreal
    Analhi Palomino
    Guillermo Sánchez
    Carlos Castro
    Clinical Rheumatology, 2015, 34 : 215 - 220
  • [47] Treatment of rheumatoid arthritis with methotrexate alone and in combination with other conventional DMARDs using the T2T strategy. A cohort study
    Ivan Santos-Moreno, Pedro
    de la Hoz-Valle, Jose
    Villarreal, Laura
    Palomino, Analhi
    Sanchez, Guillermo
    Castro, Carlos
    CLINICAL RHEUMATOLOGY, 2015, 34 (02) : 215 - 220
  • [48] Treatment Patterns of Biologic/Targeted Synthetic DMARDs for the Management of Rheumatoid Arthritis in Australia: An Analysis of the OPAL Dataset
    Cooley, Helen
    Smith, Tegan
    Youssef, Peter
    Tymms, Kathleen
    Mathers, David
    Ciciriello, Sabina
    Griffiths, Hedley
    OSullivan, Catherine
    Littlejohn, Geoffrey
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [49] Treatment Persistence Among Medicare Beneficiaries with Seropositive Rheumatoid Arthritis Initiating Biologic or Targeted Synthetic DMARDs
    Park, Sang Hee
    Schwartz, Taylor
    Han, Xue
    Robinson, Scott
    Kakehi, Sumie
    Wittstock, Keith
    Norris, Kris
    Murunga, Anne
    Silverstein, Alison
    Sparks, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 957 - 958
  • [50] Comparative safety of biologic versus conventional synthetic DMARDs in rheumatoid arthritis with COPD: a real-world population study
    Hudson, Marie
    Dell'Aniello, Sophie
    Shen, Sophie
    Simon, Teresa A.
    Ernst, Pierre
    Suissa, Samy
    RHEUMATOLOGY, 2020, 59 (04) : 820 - 827
12345